Stock data

Praxis Precision Medicines, Inc. (PRAX)

Praxis Precision Medicines, Inc. (PRAX) reported revenue of US$0.00M and net income of -US$303.27M for fiscal 2025. The figures below come from the company's SEC filings.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open Praxis Precision Medicines, Inc. in Insightr